Roee Farber, ZipBio CEO
September 5, 2024 08:00 AM EDT
Financing
Startups
AI

Ex­clu­sive: Zip­Bio launch­es us­ing gen­er­a­tive AI to make com­pact pro­teins

Ryan Cross

Senior Science Correspondent

As sev­er­al well-fund­ed com­pa­nies race to make gen­er­a­tive AI mod­els that can de­sign new pro­tein ther­a­pies from scratch, one small start­up has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Here's what to­day's Fed rate cut means for biotech, phar­ma and ven­ture cap­i­tal

FDA can­cels Ap­plied Ther­a­peu­tics ad­comm, shares sky­rock­et 65%

All of 23and­Me's in­de­pen­dent board mem­bers re­sign over dis­agree­ments with CEO

Roivant makes an­oth­er deal, sell­ing Der­ma­vant to Organon for up to $1.2B

With few ef­fi­ca­cy de­tails, In­sil­i­co claims a Phase 2a win in lat­est AI read­out

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times